EIKON THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
EIKON THERAPEUTICS, INC. (EIKN) had Common Stock, Capital Shares Reserved for Future Issuance of 11.06 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 11.06M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 11.07M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 37.56M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 11.06M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 11.07M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 37.56M shares 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |